THE THROMBIN RECEPTOR EXTRACELLULAR DOMAIN CONTAINS SITES CRUCIAL FORPEPTIDE LIGAND INDUCED ACTIVATION

Citation
Wf. Bahou et al., THE THROMBIN RECEPTOR EXTRACELLULAR DOMAIN CONTAINS SITES CRUCIAL FORPEPTIDE LIGAND INDUCED ACTIVATION, The Journal of clinical investigation, 91(4), 1993, pp. 1405-1413
Citations number
41
ISSN journal
00219738
Volume
91
Issue
4
Year of publication
1993
Pages
1405 - 1413
Database
ISI
SICI code
0021-9738(1993)91:4<1405:TTREDC>2.0.ZU;2-K
Abstract
A thrombin receptor (TR) demonstrating a unique activation mechanism h as recently been isolated from a megakaryocytic (Dami) cell line. To f urther study determinants of peptide ligand-mediated activation phenom enon, we have isolated, cloned, and stably expressed the identical rec eptor from a human umbilical vein endothelial cell (HUVEC) library. Ch inese hamster ovary (CHO) cells expressing a functional TR (CHO-TR), p latelets, and HUVECs were then used to specifically characterize alpha -thrombin- and peptide ligand-induced activation responses using two d ifferent antibodies: anti-TR34-52 directed against a 20-amino acid pep tide spanning the thrombin cleavage site,and anti-TR1-160 generated ag ainst the NH2-terminal 160 amino acids of the TR expressed as a chimer ic protein in Escherichia coli. Activation-dependent responses to both alpha-thrombin (10 nM) and peptide ligand (20 muM) were studied using fura 2-loaded cells and microspectrofluorimetry. Whereas preincubatio n of CHO-TR with anti-TR34-52 abolished only a-thrombin-induced [Ca2+] i transients, preincubation with anti-TR1-160 abrogated both alpha-thr ombin- and peptide ligand-induced responses. This latter inhibitory ef fect was dose dependent and similar for both agonists, with an EC50 of approximately 90 mug/ml. Anti-TR1-160 similarly abolished peptide lig and-induced [Ca2+]i transients in platelets and HUVECs, whereas qualit atively different responses characterized by delayed but sustained ele vations in [Ca2+]i transients were evident using alpha-thrombin. Plate let aggregation to low concentrations of both ligands was nearly aboli shed by anti-TR1-160, although some shape change remained; anti-TR34-5 2 only inhibited alpha-thrombin-induced aggregation. These data establ ish that a critical recognition sequence for peptide ligand-mediated r eceptor activation is contained on the NH2-terminal portion of the rec eptor, upstream from the first transmembrane domain. Furthermore, alph a-thrombin-induced activation of HUVECs and platelets may be partially mediated by an alternative mechanism(s) or receptor(s).